• Japanese
  • Korean
  • Chinese
Cover Image

Diabetes Diagnostics

Abstract

Description

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Million by the following Product Segments: Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, & Diabetes Tracking System), and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, & Others (Include Blood Glucose Sensors, Control Solution, and Reagent Tablets). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Abbott Diabetes Care, Bayer Diabetes Care, Bio-Rad Laboratories, Nipro Diagnostics, Inc., LifeScan, Inc., Medtronic MiniMed, Inc., Roche Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
    • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Blood Glucose Testing Devices
      • Blood Glucose Monitor
      • Diabetes Kit
      • Diabetes Tracking System
      • Blood Glucose Sensor
    • Diabetes Testing Supplies
      • Blood Glucose Test Strips
      • Lancet
      • Lancet Device
      • Reagent Strips

II. EXECUTIVE SUMMARY

1. MARKET OUTLOOK

  • Increasing Diabetes Prevalence - A Major Growth Propeller
    • Table 1: Worldwide Diabetes Market (2000 & 2025): Percentage Breakdown of Diabetes Incidence by Region - India, China, Brazil, Russia and Others (includes corresponding Graph/Chart)
  • Diabetics Cut Back Spending on Disease Management during Recession, Market Recovers from 2010

2. MARKET DYNAMICS AND TRENDS

  • Major Pharma Players - Focusing on Diabetes Diagnostics
  • Growing Emphasis on Technological Integration in Diabetes Market
  • Outlook Bright for Blood Glucose Meters and Strips
  • Self Monitoring of Blood Glucose on the Rise
  • Trends in the Glucose Meter/Monitoring Systems
  • Focus on Established Procedures Driving Growth
  • Portable Glucose Meters Fast Replacing Conventional Testing Methods
  • Point-of-Care Testing - A Profitable Venture
  • It Pays to be Customer Focused in a Mature Market
  • Advancements in Glucose Monitoring Devices - A New Ray of Hope
  • Pain-Free and Alternate-Site Glucose Monitoring
  • Continuous Glucose Monitoring
  • Up-to-the-Minute Monitoring
  • Medicare Coverage - A Strong Positive

3. COMPETITION

  • Self-Monitoring/Household Blood Glucose - Spearheading Growth
    • Table 2: Global Household Blood Glucose Monitoring Device Market (2011): Percentage Market Share Breakdown by Leading Players (includes corresponding Graph/Chart)

4. TRENDS IN DIABETES MANAGEMENT

  • Recent Advancements in Diabetes Management
  • New Developments
  • Recent Advancements in Diabetes Therapy
  • Aldose Reductase Inhibitors (ARI)
  • Advanced Glycation End-Product Inhibitors (AGEI)
  • Rising Awareness of Diabetes
  • Insulin Delivery Systems - A Potential High Growth Segment
  • Innovations in Insulin Delivery
  • Advances in Insulin Delivery - A Review
  • Pulmonary Insulin Delivery
  • Jet Injection
  • Ultrasonic Transdermal-Patch Technology
  • Insulin Delivery via Mouth Spray
  • Artificial Pancreas Technology
  • Increased Incidence of Diabetes Among HIV+

5. TECHNOLOGICAL TRENDS

  • Innovative Product Design Developments Enhance Diabetic's Quality of Life
  • Reducing Costs for Managed Care Service Providers - Emerging Trend
  • Finding Solutions Through Innovations

6. BLOODLESS TESTING - AN OVERVIEW

  • Non-invasive Blood Glucose Testing - Still in Experimental Stage
  • High Price - A Major Hurdle

7. A PEEK INTO OTC/PHYSICIANS' OFFICE DIABETES TESTS MARKET

  • In-home Tests: Making Health Control Easier
  • Common OTC Tests
  • Glucose Monitor
  • Cholesterol
  • Major Market Segments in OTC/Physicians' Office Diabetes Tests
  • Urine Strips
  • Blood Glucose Strips: A Well Established Market
  • Blood Glucose Meters
  • PBGM Devices: Based on Photometric or Biosensor Technology

8. LABORATORY DIABETES TESTS MARKET - A PRIMER

  • Various Types of Laboratory Diabetes Tests
  • Blood Glucose & Related Tests
  • Fructosamine Tests: To Diagnose Gestational Diabetes
  • Glycosylated Hemoglobin Tests: A Promising Approach in Diagnosing Diabetes Mellitus
  • Glycosylated Haemoglobin Tests - Paving Way for Early Stage Diabetes Diagnosis
  • Immunoassays (Anti-Insulin and Anti-Islet Antibodies)
    • It Pays to Introduce Advanced Instruments
  • Urine Ketones and Microalbuminuria: To Test Type I Diabetes
    • Diabetic Renal Disease with Reference to Microalbuminuria
  • All Other Diabetes Tests
  • Diabetes Tests
  • Fasting Plasma Glucose Test
  • Casual Glucose Test

9. DIABETES DIAGNOSTICS - AN OVERVIEW

  • Cost - The Ultimate Factor in the Choice of Blood Glucose Monitoring Systems
  • Classification
  • Blood Glucose Testing Devices
  • Blood Glucose Monitor/Meter
    • Select Blood Glucose Meters Based on Test Strips
    • Diabetes Kit
    • Diabetes Tracking System
    • Blood Glucose Sensor
  • Diabetes Testing Supplies
    • Blood Glucose Test Strips
    • Lancet
    • Lancet Device
    • Reagent Strips
    • Reagent Tablet

10. DIABETES: A CHRONIC BODY DISORDER

  • Diabetes Symptoms
  • Diabetes: One of the Leading Causes of Death in Developed Countries
  • Types of Diabetes
  • Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
  • Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)
  • NIDDM Might Lead to Cardiovascular Complications
  • Increasing Occurrence of Type II Diabetes Worldwide
    • Factors Influencing Type 2 diabetes
  • Agents Used for Type 2 Diabetes Treatment
  • Diabetes: A Major Healthcare Challenge
  • Etiological Factors Causing Diabetes
  • Insulin Types
  • Diabetes-Related Complications
  • Complications Associated with Diabetes - In a Nutshell
  • Heart Disease
  • Stroke
  • High Blood Pressure
  • Blindness
  • Kidney Disease
  • Nerve Disease
  • Amputations
  • Dental Disease
  • Pregnancy
  • Possible Complications of Diabetes
  • Microvascular Complications (Small Blood Vessel Damage)
  • Macrovascular Complications (Large Blood Vessel Damage)
  • Other Complications
    • Microvascular Complications (Small Blood Vessel Damage)
      • Retinopathy
      • Diabetic Neuropathy
      • Nephropathy
    • Macrovascular Complications (Large Blood Vessel Damage)
      • Cardiac Problems
      • Hypertension (High Blood Pressure)
    • Other Major Complications
      • Infections
      • Impotence
      • Pregnancy Complications
  • Other Complications Resulting from Diabetes
  • Obesity
  • Obsessive Compulsive Disorder
  • Foot Ulcers
  • Dementia and its Association with Diabetes
  • Hypoglycemia
  • Diabetic Ketoacidosis
  • Undiagnosed Diabetics: More Prone to Cardiovascular Diseases

11. DIABETES INCIDENCE AND PREVALENCE

    • Table 3: Worldwide Prevalence of Diabetes Mellitus by Region: 2010 & 2030 (includes corresponding Graph/Chart)
  • Diabetes Mellitus Cases Worldwide - A Demographic Analysis by Geographic Region
  • North America
    • United States
    • Canada
    • Mexico
    • Table 4: Prevalence of Diabetes Mellitus in North America (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)
  • Europe
    • Table 5: Prevalence of Diabetes Mellitus in Europe (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %)
  • Asia-Pacific
    • Southeast Asian Region
    • Western Pacific Region
    • Table 6: Prevalence of Diabetes Mellitus in South East Asia (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)
    • Table 7: Prevalence of Diabetes Mellitus in Western Asia (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)
  • South & Central America
    • Type-1 Diabetes
    • Type-2 Diabetes
    • Table 8: Prevalence of Diabetes Mellitus in South & Central America (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %
  • Rest of World
    • Table 9: Prevalence of Diabetes Mellitus in Africa (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %)
    • Table 10: Prevalence of Diabetes Mellitus in The Middle East & North Africa (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)

12. PRODUCT INTRODUCTIONS/INNOVATIONS

  • LifeScan Introduces New System for Testing Blood Glucose
  • Bayer Diabetes Care Launches Blood Glucose Meter
  • Bayer Introduces CONTOUR(R) USB
  • Roche Diagnostics Unveils Accu-Check Mobile Device in the UK
  • ARKRAY Unveils New Assure(r) Pro Blood Glucose Monitoring Strip
  • TRCL and Entra Health Systems Introduce AmCare Cell Phone Supported Diabetes Management Services
  • Home Diagnostics Announces the US Launch of TRUE2go Blood Glucose Monitor
  • AgaMatrix Launches Kroger BGM
  • ARKRAY Obtains FDA Approval for GLUCOCARD(r) Vital(tm) BGM
  • Bayer Receives FDA Approval for Marketing CONTOUR USB
  • Medtronic Rolls Out Paradigm Veo
  • Home Diagnostics Introduces TRUEmanagerTM Diabetes Management Software
  • Fora Care to Introduce Affordable Diabetes Care Solutions
  • Roche Diagnostics Introduces Accu-Chek Smart Pix
  • Entra Launches MyGlucoHealth Meter in the US
  • ACON Unveils On Call(r) Plus Blood Glucose Monitoring System in US

13. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER

  • Arkray and Piramal Introduce Advanced Glucocard 01
  • BodyTel Scientific to Introduce GlucoTel System
  • Bio-Rad Launches Liquichek(tm) Diabetic Control
  • Home Diagnostics Introduces TRUEread
  • Medtronic's CGMS(r) iPro(tm) Receives FDA Approval
  • Siemens Introduces the DCA Vantage(tm) Analyzer
  • Arkray Introduces Analyzers for Diabetes Testing
  • Bayer Releases Brio(r) and Breeze(r) Diabetes Management Systems in South Korea and China
  • GenExel-Sein Introduces DUO-CARE(tm) Home-Use Diabetes Products
  • HemoCue Unveils New Testing System for Point of Care Use
  • LifeScan Launches Easy-to-Use Glucose Meter
  • Roche Rolls Out ACCU-CHEK(r) Spirit Insulin Pump System
  • Novo Nordisk Introduces Simple-to Use GlucaGen(r) HypoKit(tm)
  • Biomerica Launches New Diabetes Diagnostic Test
  • Hypoguard Introduces New Glucose Meter
  • Bio-Rad Launches VARIANT(tm) II TURBO Monitoring System
  • Roche Launches Accu-Chek Go for Blood Glucose Monitoring
  • Roche Diagnostics Launches Accu-Chek Lancing System
  • LifeScan Introduces Glucose Meter in India
  • Abbott Laboratories Introduces Two New Glucose Meters in Europe
  • HDI Launches KetoCare(tm) Ketone Test Strips
  • Roche Diagnostics Unveils Accu-Chek D-TRON Plus
  • Abbott Introduces Precision Xtra(tm) Advanced Diabetes Management System
  • Abbott Diabetes Care Launches Precision Xtra(tm) Blood Glucose Test Strip
  • LifeScan Introduces Onetouch Horizon
  • Bayer Diagnostics Unveils Ascensia(r) CONTOUR(tm) Blood Glucose Monitoring System

14. RECENT INDUSTRY ACTIVITY

  • Home Diagnostics and Nipro Diabetes to Merge to Form Nipro Diagnostics
  • IVAX Diagnostics Inks Product Distribution Agreement with Biomerica
  • Terumo Spins-Off Diabetes Business
  • Premier Inks Alliance with Healthcare Companies
  • AgaMatrix and Sanofi-Aventis to Co-Develop Blood Glucose Monitoring Solutions
  • Nippon Product Merges with Home Diagnostics
  • PositiveID Purchases Assets and Intellectual Property Rights of Easy Check
  • Sanvita CBGM Acquires Assets of Sanvita
  • ARKRAY Secures FDA 510k Clearance for Assure(r) Platinum
  • Brazos Subsidiary to Merge with Epinex

15. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • Neighborhood Diabetes Takes Over New York Diabetic Supply
  • Home Diagnostics Enters into an Exclusive Supply Deal with Rite Aid Pharmacy Chain
  • OPG Acquires Hahn & Hahn
  • Nanobac Agrees to Acquire DNAPrint Genomics
  • Novo Nordisk's R&D Plans in India
  • Medco Health Solutions Announces Acquisition of PolyMedica
  • PolyMedica Takes over QualityCare
  • NationsHealth Acquires Diabetes Care & Education
  • Inverness Acquires Cholestech
  • WaveSense Launches European Subsidiary
  • XMDC, Diabetes Detection Sign on Distribution Agreement
  • IQMC Agrees on Acquisition of Lifecare AS
  • Bayer's Contour TS Test Strip Market Recall
  • BBI Acquires CDx and Audiometrics
  • Bayer Receives Ease-Of-Use Commendation for Ascensia(r) BREEZE(r) Blood Glucose Monitoring System
  • BYETTA(r) (exenatide) Receives Marketing Authorization from European Commission
  • Bayer Diabetes Care Acquires Metrika
  • BD Walks Out of BGM Market
  • Bio-Rad Acquires Provalis' Medical Diagnostics Division
  • Bio-Rad Inks Multi-Year Agreement with Premier
  • Cholestech and Life Line Collaborate Over Diagnostic Testing
  • FDA Approves Medtronic's MiniMed Paradigm(r) RT CGM System
  • FDA Clears Abbott's FreeStyle(r) Freedom(tm) Blood Glucose Meter
  • FDA Approves Hypoguard's Blood Glucose Monitor
  • FDA Approves DexCom's Continuous Glucose Monitoring System
  • Johnson & Johnson Acquires Animas Corporation
  • LifeScan and NIR Agree on Extension of First Option Agreement
  • Pfizer Obtains Global Rights to Inhalable Human Insulin - Exubera(r)
  • Roche Receives FDA Clearance for Acu-Check Insulin Pump
  • Sphere Medical and Analogic Team up for Monitoring Solutions
  • NeuroMetrix Wins Exclusive Marketing License of DigiScope
  • FDA Recommends Exubera(r) for Diabetic Patients
  • Bio-Rad and Sysmex Ink Co-Marketing Agreement
  • Diabetes Gold Forms Joint Venture with BioTex Labs
  • FDA Grants 510(k) Clearance for Abbott's Freestyle Connect(tm) Blood Glucose Meter
  • FDA Clears Hypoguard's Advance Micro-draw(tm) Blood Glucose System
  • FDA Approves Home Diagnostics' Blood Glucose Testing System
  • Insulet Corporation and Solectron Collaborate to Develop OmniPod(tm)
  • PolyMedica Acquires National Diabetic Pharmacies
  • Cygnus, Inc. Divests its Glucose-Monitoring Assets
  • Home Diagnostics' Blood Glucose Monitor Features in Best Rx Value Drug List of Ohio
  • Roche Diagnostics Receives US FDA Approval for its Latest Blood Glucose Meter
  • Provalis Ships in2it A1C to US
  • Hitachi Develops Unique Non-Invasive Device for Diabetes Monitoring
  • Bayer Diagnostics Business Splits into Two Units
  • Abbott Laboratories Acquires TheraSense Inc.
  • Roche Acquires Infusion Systems Division of Disetronic
  • Bristol-Myers Squibb Enters into Alliance with Merck
  • Provalis Receives FDA Approval
  • Gunze Enters into an Agreement with Sanko Junyaku Strike
  • Health Hero Network Receives US FDA Approval
  • Roche Diagnostics Corporation Receives Contract from Premier Inc
  • Vitro Introduces Stem Cell Therapy for Diabetes
  • Home Diagnostics' Blood Glucose Monitor Features in RxAmerica National Formulary
  • Home Diagnostics' Blood Glucose Monitor Features in Procare Rx National Formulary
  • Medtronic Receives FDA Approval for its New Continuous Glucose Monitoring System
  • Roche Diagnostics Awarded Blood Glucose and Lancet Contracts
  • HDI's TrueTrack Smart System Wins FDA Approval for AST
  • Seradyn Bags US FDA Clearance for HbA1c Assay
  • Bristol-Myers Squibb Receives Exclusive Rights to AlcNow Diabetes Monitor
  • Bio-Rad Laboratories Awarded 510(k) Clearance for VARIANT(tm) II TURBO

16. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Diabetes Care (US)
  • Bayer Diabetes Care (US)
  • Bio-Rad Laboratories (US)
  • Nipro Diagnostics, Inc. (US)
  • LifeScan, Inc. (US)
  • Medtronic MiniMed, Inc. (US)
  • Roche Diagnostics (Switzerland)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthcare Diagnostics (US)

17. GLOBAL MARKET PERSPECTIVE

    • Table 11: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 13: World 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Blood Glucose Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Blood Glucose Testing Devices by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 16: World 15-Year Perspective for Blood Glucose Testing Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 17: World Recent Past, Current & Future Analysis for Blood Glucose Testing Devices by Product Segment - Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 18: World Historic Review for Blood Glucose Testing Devices by Product Segment - Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 19: World 15-Year Perspective for Blood Glucose Testing Devices by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets for Years 2003, 2011, & 2017 (includes corresponding Graph/Chart)
    • Table 20: World Recent Past, Current & Future Analysis for Blood Glucose Test Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Blood Glucose Test Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 22: World 15-Year Perspective for Blood Glucose Test Kits by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for Blood Glucose Meters/Monitors by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Blood Glucose Meters/ Monitors by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 25: World 15-Year Perspective for Blood Glucose Meters/Monitors by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Diabetes Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Diabetes Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 28: World 15-Year Perspective for Diabetes Kits by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 29: World Recent Past, Current & Future Analysis for Diabetes Tracking Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 30: World Historic Review for Diabetes Tracking Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 31: World 15-Year Perspective for Diabetes Tracking Systems by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 32: World Recent Past, Current & Future Analysis for Diabetes Testing Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 33: World Historic Review for Diabetes Testing Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 34: World 15-Year Perspective for Diabetes Testing Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 35: World Recent Past, Current & Future Analysis for Diabetes Testing Supplies by Product Segment - Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 36: World Historic Review for Diabetes Testing Supplies by Product Segment - Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 37: World 15-Year Perspective for Diabetes Testing Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 38: World Recent Past, Current & Future Analysis for Blood Glucose Test Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 39: World Historic Review for Blood Glucose Test Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 40: World 15-Year Perspective for Blood Glucose Test Strips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 41: World Recent Past, Current & Future Analysis for Lancets by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 42: World Historic Review for Lancets by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 43: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 44: World Recent Past, Current & Future Analysis for Lancet Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 45: World Historic Review for Lancet Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 46: World 15-Year Perspective for Lancet Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 47: World Recent Past, Current & Future Analysis for Reagent Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 48: World Historic Review for Reagent Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 49: World 15-Year Perspective for Reagent Strips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 50: World Recent Past, Current & Future Analysis for Other Diabetes Diagnostic Products/Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 51: World Historic Review for Other Diabetes Diagnostic Products/Supplies by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 52: World 15-Year Perspective for Other Diabetes Diagnostic Products/Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Glucose Monitoring Market Bounces Back, Post Recession
    • Competitive Landscape
    • Table 53: US Blood Glucose Monitoring Market (2011) : Percentage Share Breakdown for Leading Brands (includes corresponding Graph/Chart)
    • Diabetes Prevalence in the US by Type
    • Table 54: Diabetes Prevalence in the US by Type: 2008 (includes corresponding Graph/Chart)
    • Diabetes: A Leading Cause of Death in the US
    • Market Trends
      • Companies Focus on Research for Better Diabetes Diagnostics
      • Focus on Established Procedures Driving Growth
      • Insulin Delivery Systems - A Potential High Growth Segment
      • Competitive Landscape
      • Roche Losing its Share in the US Blood Glucose Monitors Market
  • B. Market Analytics
    • Table 55: The US Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 56: The US Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 57: The US 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Diabetes Incidence
  • B. Market Analytics
    • Table 58: Canadian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 59: Canadian Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, And Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 60: Canadian 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) And Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Growing Aging Population Drives Diabetes Diagnostics Market
    • Other Trends Influence Diabetes Diagnostics Market
  • B. Market Analytics
    • Table 61: Japanese Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 62: Japanese Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 63: Japanese 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Significant Increase in the Number of Diabetics
  • B. Market Analytics
    • Table 64: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 65: European Historic Review for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 66: European 15-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 67: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 68: European Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 69: European 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analytics
    • Table 70: French Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, And Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 71: French Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 72: French 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analytics
    • Table 73: German Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 74: German Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 75: German 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analytics
    • Table 76: Italian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 77: Italian Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 78: Italian 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analytics
    • Table 79: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 80: UK Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 81: UK 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • Market Analytics
    • Table 82: Rest of European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 83: Rest of European Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 84: Rest of European 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Medical Devices Market Poised to Grow
    • Technological Integration: An Emerging Trend in the Asia- Pacific Medical Devices Market
    • Public and Private Sector Diabetes Care
      • Public Sector
      • Private Sector
    • Cost Prohibits Penetration of Continuous Monitoring Devices
    • Role of Healthcare Societies and Associations
      • India
      • Bangladesh
    • Western Pacific Declaration on Diabetes
    • India
      • Market Overview
      • Glucometer Prices on the Downward Spiral
      • Market Restraints
      • Key Statistics
    • Table 85: Indian Diabetes Care Devices Market (2011) : Percentage Market Share Breakdown for Leading Manufacturers (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 87: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 88: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • National Diabetes Programs
    • Guidelines for Diabetes Care
    • Key Statistics
    • Table 89: Brazilian Diabetes Care Device Market (2011) : Percentage Market Share Breakdown for Leading Manufacturers (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 90: Latin American Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 91: Latin American Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 92: Latin American 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analytics
    • Table 93: Rest of World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 94: Rest of World Historic Review for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 95: Rest of World 15-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, and Reagent Strip) and Other Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
RELATED REPORTS
* Europe Diabetes Management Market Opportunity and Growth Trend Forecast Till 2019
  • Published:
  • May 02, 2014
  • USD 4200
  • 110 Pages

* India Diabetes Management Devices Market Report, 2006 - 2019
  • Published:
  • May 02, 2014
  • USD 3000
  • 52 Pages

* Japan Market for Diabetes Management Devices Through 2019
  • Published:
  • May 02, 2014
  • USD 3000
  • 52 Pages

* Blood Glucose Testing and Diabetes Management
  • Published:
  • May 01, 2014
  • USD 3400
  • 296 Pages

* U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014
  • Published:
  • May 01, 2014
  • USD 6995
  • 226 Pages

* Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018
  • Published:
  • Apr 01, 2014
  • USD 4650
  • 372 Pages

* mhealth Apps & Solutions Market By Connected Devices (Cardiac Monitoring, Diabetes Management Devices), Health Apps (Exercise, Weight Loss, Women's Health, Sleep and Meditation), Medical Apps (Medical Reference) - Global Trends & Forecast to 2018
  • Published:
  • Sep 09, 2013
  • USD 4650
  • 277 Pages

* In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
  • Published:
  • Jul 31, 2013
  • USD 4595
  • 124 Pages

* European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017
  • Published:
  • Jul 05, 2013
  • USD 4650
  • 333 Pages

* Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth
  • Published:
  • Jun 03, 2013
  • USD 3500
  • 130 Pages

Browse more Patient Monitoring Market Research Reports

Pricing
Get Notified
Email me when related reports are published